Patrick J. Creaven

4.8k total citations
127 papers, 3.9k citations indexed

About

Patrick J. Creaven is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick J. Creaven has authored 127 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 50 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick J. Creaven's work include Cancer Treatment and Pharmacology (26 papers), Cancer therapeutics and mechanisms (24 papers) and Colorectal Cancer Treatments and Studies (21 papers). Patrick J. Creaven is often cited by papers focused on Cancer Treatment and Pharmacology (26 papers), Cancer therapeutics and mechanisms (24 papers) and Colorectal Cancer Treatments and Studies (21 papers). Patrick J. Creaven collaborates with scholars based in United States, Japan and Canada. Patrick J. Creaven's co-authors include Lakshmi Pendyala, Larry M. Allen, Youcef M. Rustum, Mary K. Roach, Nicholas J. Petrelli, Oleg S. Selawry, William M. McIsaac, H.H. Hansen, Maurice Cohen and Franco M. Muggia and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Patrick J. Creaven

126 papers receiving 3.7k citations

Peers

Countries citing papers authored by Patrick J. Creaven

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Creaven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Creaven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Creaven more than expected).

Fields of papers citing papers by Patrick J. Creaven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Creaven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Creaven. The network helps show where Patrick J. Creaven may publish in the future.

Co-authorship network of co-authors of Patrick J. Creaven

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Creaven. A scholar is included among the top collaborators of Patrick J. Creaven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Creaven. Patrick J. Creaven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors 2007 ·Cancer Chemotherapy and Pharmacology ·Marwan Fakih, Lakshmi Pendyala, William E. Brady, Patrick F. Smith, Mary Ellen Ross, Patrick J. Creaven, Vladimir Badmaev, Joshua Prey, Youcef M. Rustum	31
2	Expression of Genes Related to Activity of Oxaliplatin and 5-Fluorouracil in Endoscopic Biopsies of Primary Esophageal Cancer in Patients Receiving Oxaliplatin, 5-Flourouracil and Radiation: Characterization and Exploratory Analysis with Survival 2006 ·Journal of Chemotherapy ·Lawrence Leichman, David Lawrence, Cynthia G. Leichman, (unknown), Edna Nava, (unknown), Kimberly Clark, Nikhil I. Khushalani, (unknown), William R. Greco, Patrick F. Smith, Patrick J. Creaven, (unknown), Milind Javle, Lakshmi Pendyala	12
3	A phase I and pharmacokinetic (PK) study of intravenous (IV) calcitriol and gefitinib assessing EGFR pharmacodynamic (PD) interactions through serial skin biopsies 2005 ·Cancer Research ·Marwan Fakih, Candace S. Johnson, Josephia R. Muindi, Jennifer D. Black, Patrick J. Creaven, Michael G. Brattain, James L. Kepner, (unknown), Donald L. Trump	1
4	S-phase modulation by irinotecan: pilot studies in advanced solid tumors 2005 ·Cancer Chemotherapy and Pharmacology ·Nithya Ramnath, Nikhil I. Khushalani, Károly Tóth, Alan Litwin, Marilyn Intengan, Harry K. Slocum, Lakshmi Pendyala, Patrick F. Smith, (unknown), (unknown), Milind Javle, (unknown), Patrick J. Creaven, Youcef M. Rustum	11
5	Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer 2000 ·Cancer Chemotherapy and Pharmacology ·D H Ho, (unknown), N Brown, (unknown), Richard Pazdur, (unknown), Patrick J. Creaven, (unknown), Neal J. Meropol, Yvonne Lassere, (unknown), Tomohisa Hayakawa	18
6	Octreotide Does Not Prevent Diarrhea in Patients Treated With Weekly 5-Fluorouracil Plus High-Dose Leucovorin 1998 ·American Journal of Clinical Oncology ·Neal J. Meropol, Leslie E. Blumenson, Patrick J. Creaven	14
7	A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer 1996 ·Cancer Chemotherapy and Pharmacology ·N J Meropol, (unknown), Nicholas J. Petrelli, Miguel A. Rodrı́guez-Bigas, Cheryl Frank, D H Ho, (unknown), Patrick J. Creaven	56
8	Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells 1996 ·Cancer Letters ·Zeyad El-Akawi, (unknown), Raymond P. Perez, Joseph S. Glavy, Joseph Zdanowicz, Patrick J. Creaven, Lakshmi Pendyala	63
9	A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patients with colorectal carcinoma 1995 ·Investigational New Drugs ·Neal J. Meropol, (unknown), Youcef M. Rustum, Miguel A. Rodrı́guez-Bigas, Leslie E. Blumenson, Cheryl Frank, Elmer Berghorn, Patrick J. Creaven	3
10	Clinical Studies of the Modulation of Ftorafur 1993 ·Advances in experimental medicine and biology ·Patrick J. Creaven, (unknown), Nicholas J. Petrelli, Vera Gorbunova	6
11	5-Fluoro-2′-Deoxyuridine: Role of Schedule in its Therapeutic Efficacy 1993 ·Advances in experimental medicine and biology ·Shousong Cao, (unknown), Patrick J. Creaven, Youcef M. Rustum	4
12	Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma 1993 ·Cancer ·Nicholas J. Petrelli, Miguel A. Rodrı́guez-Bigas, Youcef M. Rustum, Lemuel Herrera, Patrick J. Creaven	33
13	A Phase I Study of Cisplatinum plus 5-Fluorouracil in Modulation with Citrovorum Factor in Metastatic Colorectal Carcinoma 1991 ·Journal of Chemotherapy ·S. Palmeri, Vittorio Gebbia, Anna Russo, Youcef M. Rustum, L Rausa, Patrick J. Creaven, Nicholas J. Petrelli	1
14	Response to tumor necrosis factor in two cases of psoriasis 1991 ·Journal of the American Academy of Dermatology ·Patrick J. Creaven, Howard L. Stoll	20
15	Clinical pharmacokinetics of 3-deazaguanine 1991 ·Cancer Chemotherapy and Pharmacology ·Lakshmi Pendyala, Patrick J. Creaven, Lloyd R. Whitfield	1
16	DNA binding of iproplatin and its divalent metabolitecis-dichloro-bis-isopropylamine platinum(II) 1990 ·Cancer Chemotherapy and Pharmacology ·Lakshmi Pendyala, (unknown), (unknown), J. Wayne Cowens, Patrick J. Creaven	33
17	Uptake and metabolism of iproplatin in murine L1210 cells 1989 ·Cancer Chemotherapy and Pharmacology ·Lakshmi Pendyala, (unknown), (unknown), (unknown), J. Wayne Cowens, Patrick J. Creaven	8
18	Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks 1989 ·Cancer Chemotherapy and Pharmacology ·Patrick J. Creaven, J. Wayne Cowens, Robert P. Huben, Nicholas J. Petrelli, Constantine P. Karakousis, (unknown)	2
19	Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. 1988 ·Journal of Clinical Oncology ·Fabio Trave, Youcef M. Rustum, Nicholas J. Petrelli, L Herrera, A Mittelman, C Frank, Patrick J. Creaven	61
20	A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. 1987 ·Journal of Clinical Oncology ·Nicholas J. Petrelli, L Herrera, Youcef M. Rustum, P. J. Burke, Patrick J. Creaven, Jaroslav P. Stulc, Lawrence J. Emrich, A Mittelman	362

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact